Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

CASI Pharmaceuticals Inc (NASDAQ:CASI)

2.44
Delayed Data
As of Oct 17
 -0.26 / -9.63%
Today’s Change
0.91
Today|||52-Week Range
4.84
+112.17%
Year-to-Date

Today’s Trading

Previous close2.70
Today’s open2.73
Day’s range2.31 - 2.75
Volume742,779
Average volume (3 months)375,871
Market cap$162.5M
Dividend yield--
Data as of 10/17/2017

Growth & Valuation

Earnings growth (last year)+22.73%
Earnings growth (this year)+14.71%
Earnings growth (next 5 years)--
Revenue growth (last year)-100.00%
P/E ratioNM
Price/Sales--
Price/Book7.82

Competitors

 Today’s
change
Today’s
% change
ECYTEndocyte Inc+0.04+1.05%
ATXIAvenue Therapeutics ...-0.08-1.52%
XENEXenon Pharmaceutical...+0.08+2.40%
APDNApplied DNA Sciences...-0.30-11.86%
Data as of 10/17/2017

Financials

Next reporting dateNovember 13, 2017
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$0.00
Annual profit (last year)-$9.5M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Ken Keyong Ren
COO, Secretary, Vice President &
General Counsel
Cynthia Wong Hu
Corporate headquarters
Rockville, Maryland

Forecasts